Opinion
Video
Author(s):
Dr. Chapin and fellow expert oncologists discuss the latest data from the LIGHTHOUSE trial, evaluating 18F-rhPSMA-7.3 for staging patients with prostate cancer.
FDA clears AI-powered application for measuring prostate volume
Dr. Murphy on increasing diversity in cancer clinical trials
AUA 2025: What to watch for in urologic oncology
Dr. Schwen on focal therapies for prostate cancer
Dose expansion begins in phase 1/2 trial of 67Cu-SAR-bisPSMA in mCRPC
Study underway to assess 3-fraction SBRT regimen in prostate cancer